Udo Bavendiek

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure (DIGIT-HF): Baseline Characteristics Compared to Recent Randomized Controlled Heart Failure Trials

The DIGIT-HF Trial: Key Amendments of Study Design

Die digitalen Fortschrittshubs Gesundheit – Gemeinsame Datennutzung über die Universitätsmedizin hinaus

Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial

Expert opinion paper on cardiac imaging after ischemic stroke

IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation

Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy

Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study

Digoxin–mortality: randomized vs. observational comparison in the DIG trial

Gut Microbiota–Dependent Trimethylamine <i>N</i> -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes

HiGHmed – An Open Platform Approach to Enhance Care and Research across Institutional Boundaries

Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure

Simultaneous GC-ECNICI-MS measurement of nitrite, nitrate and creatinine in human urine and plasma in clinical settings

Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy

Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy

First series of mechanical circulatory support in non-compaction cardiomyopathy: Is LVAD implantation a safe alternative?

Interleukin-1 Assembles a Proangiogenic Signaling Module Consisting of Caveolin-1, Tumor Necrosis Factor Receptor–Associated Factor 6, p38–Mitogen-Activated Protein Kinase (MAPK), and MAPK-Activated Protein Kinase 2 in Endothelial Cells